Karbetocin Avmc

Carbetocin, the active ingredient in Karbetocin Avmc, is an oxytocin analog presented as an injectable solution for intravenous use. It is employed to prevent and treat postpartum hemorrhage and uterine atony in women after delivery.

GNH USA supplies Karbetocin Avmc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Karbetocin is an oxytocin‑type uterotonic used in obstetric care to control bleeding.

- Postpartum hemorrhage: reduces excessive bleeding after vaginal or cesarean delivery. - Uterine atony: stimulates uterine smooth‑muscle contraction to restore tone. - Obstetric surgery: supports uterine contraction during and after surgical procedures to minimise blood loss.

Carbetocin may cause a range of adverse reactions. Monitoring for side effects is part of routine clinical care.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Flushing: temporary redness of skin. - Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects: - Severe hypertension: marked elevation of blood pressure requiring intervention. - Cardiac arrhythmia: abnormal heart rhythm. - Allergic reaction: rash, itching, or anaphylaxis. - Uterine rupture: rare but life‑threatening tearing of the uterus.

Before using Karbetocin, clinicians should consider several safety aspects.

- Cardiovascular status: assess blood pressure and heart rhythm. - Fluid balance: monitor for signs of fluid overload. - Pre‑existing uterine conditions: evaluate for scar tissue or previous rupture. - Concomitant uterotonics: avoid simultaneous use with other agents that increase uterine tone. - Allergies: verify no known hypersensitivity to carbetocin or oxytocin analogs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Carbetocin can interact with other medications that affect cardiovascular or uterine function.

Major Interactions (Avoid): - Vasopressors (e.g., epinephrine): may exacerbate hypertension. - Magnesium sulfate: can potentiate uterine relaxation, reducing efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood‑pressure lowering effect. - Other uterotonics (e.g., oxytocin, misoprostol): increase risk of uterine hyperstimulation. - Anesthetic agents: may alter hemodynamic response during surgery.